Clinical trials: Cardiovascular Outcomes
Coronary Heart Disease
Clinical Characteristics and Outcomes of Coronary Heart Disease
This study evaluated and compared the prognostic value of different Baseline data and clinical variables to develop predictive model in patients with CHD.
- Trial name
- IMPROVE (NCT06335901)
- Testing
- Drug:Standard therapy
- Where
- China
- Volunteers
- 20,000 people
- Sponsor
- Xinjiang Medical University
Cerebrovascular Disorders
Improving Stroke Care in Greece in Terms of Management, Costs and Health Outcomes-
The main objectives of the proposed project are: 1. To provide essential data on acute stroke management (quality indicators) incorporating hard clinical outcomes that will contribute to an ongoing process of quality improvement…
- Trial name
- SUN4P (NCT04109612)
- Where
- 10 sites in Greece
- Volunteers
- 913 people
- Sponsor
- National and Kapodistrian University of Athens
Cardiovascular Surgery
Cardiovascular Surgery Early Prediction System for AKI :CARDS-AKI Registry
This multicenter, prospective study prospectively enrolled patients undergoing cardiovascular surgery. Detailed perioperative clinical data and biospecimens were collected at multiple time points.
- Trial name
- NCT07330453
- Testing
- Observation
- Where
- China
- Volunteers
- 5,000 people, healthy volunteers welcome
- Sponsor
- Chinese Academy of Medical Sciences, Fuwai Hospital
Cardiovascular Disease, Mitral Valve Repair
Carbon Dioxide Insufflation on Cerebral Microemboli
The purpose of this study is to determine if blowing carbon dioxide into the surgical field during open-heart surgery to displace retained chest cavity air from the atmosphere will decrease the number of microembolic being…
- Conditions
- Cardiovascular Disease, Mitral Valve Repair, Cerebral Microemboli, Cognitive Decline
- Trial name
- NCT00715845
- Testing
- Carbon dioxide insufflation
- Where
- Canada
- Volunteers
- 20 people
- Sponsor
- University Health Network, Toronto
Acute Stroke, Transient Ischemic Attack
Motivational Interviewing for Stroke
Motivational interviewing (MI) is a style of communication designed to elicit a person's own reasons for change to drive commitment toward a goal.
- Trial name
- NCT06195007
- Testing
- Motivational Interview
- Where
- United States
- Volunteers
- 1 people
- Sponsor
- University of Florida
Intracranial Aneurysm
Supraphysiologic Insulin to Improve Outcomes After Surgical Treatment of Unruptured Cerebral Aneurysms
We hypothesize that in patients undergoing surgical treatment of unruptured intracranial aneurysms, the increase in blood sugar as a result of surgical stress is detrimental to outcome, as measured by blood levels of proteins…
- Trial name
- NCT00615381
- Testing
- Insulin
- Where
- United States
- Sponsor
- Northwestern University
Atherosclerosis
Study to Gain Insights in Treatment Patterns and Outcomes in Patients With Atherosclerosis Prescribed to Xarelto in Combination With Acetylsalicylic Acid
In this study researchers want to gain more information on treatment patterns of patients treated with Xarelto in combination with acetylsalicylic acid (ASA). Both drugs reduce the risk of blood clots via different pathways.
- Trial name
- XATOA (NCT03746275)
- Testing
- Rivaroxaban (BAY59-7939, Xarelto), Acetylsalicylic acid
- Where
- 18 sites in Argentina, Brazil and 16 more
- Volunteers
- 5,798 people
- Sponsor
- Bayer
Heart Failure, Congestive Heart Failure
Leveraging Home Health Aides to Improve Outcomes in Heart Failure
The purpose of the study is to determine the effectiveness of an intervention among home health aides caring for adults admitted to home care with a primary diagnosis of heart failure at VNS Health Partners in Care (home care…
- Trial name
- NCT04239911
- Testing
- mHealth app, Virtual training course
- Where
- United States
- Volunteers
- 105 people
- Sponsor
- Weill Medical College of Cornell University
Multiple Myeloma, Relapsed, Multiple Myeloma (MM)
Quality of Life and Treatment Outcomes in RRMM Patients Receiving Advanced vs. Conventional Immunotherapies
This is a non-interventional observational study aiming to evaluate the quality of life, efficacy, and safety of advanced immuno-oncology agents versus conventional immuno-oncology therapies in patients with relapsed or…
- Trial name
- NCT07051850
- Testing
- Bispecific antibody, Antibody-Drug Conjugate, Monoclonal antibody
- Where
- South Korea
- Volunteers
- 174 people
- Sponsor
- Sung-Soo Park
Coronary Arteriosclerosis, Angina Pectoris
Randomized Comparison Angioplasty Outcomes at Hospitals With and Without On-site Cardiac Surgery
Angioplasty is a procedure which opens blocked heart arteries using balloons and/or stents. Most U.S. states and all national heart organizations require that angioplasty be done only at hospitals that can also perform open heart…
- Trial name
- NCT00549796
- Testing
- Percutaneous coronary intervention (PCI)
- Where
- 60 sites in United States
- Volunteers
- 18,876 people
- Sponsor
- Johns Hopkins University
Ischemic Stroke, Covid19
Acute Revascularization Treatment in Ischemic Stroke Patients With COVID-19
Case-series and cohort studies have shown the feasibility of reperfusion therapies in patients with ischemic stroke and COVID-19, but due to the absence of a contemporary control group of non-COVID-19 patients, small sample size…
- Trial name
- NCT04895462
- Where
- Switzerland
- Volunteers
- 15,128 people
- Sponsor
- Centre Hospitalier Universitaire Vaudois
Ischemic Stroke, Covid 19
Endovascular Thrombectomy in COVID-19 Infected Patients
About 5% of COVID-19 patients may present symptoms related to acute ischemic stroke (AIS). Treatment-management and outcomes related to mechanical thrombectomy (MT) for COVID-19 infected patients harboring large vessel occlusion…
- Trial name
- ET-COVID-19 (NCT04406090)
- Testing
- Mechanical Trombectomy
- Where
- France
- Volunteers
- 50 people
- Sponsor
- University Hospital, Montpellier
Atherosclerosis
IMPact on Revascularization Outcomes of IVUS Guided Treatment of Complex Lesions and Economic Impact
Intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) has been shown in clinical trials, registries, and meta-analyses to reduce recurrent events after PCI.
- Trial name
- IMPROVE (NCT04221815)
- Testing
- Eagle Eye Platinum digital IVUS catheter with optional SyncVision, Resolute Onyx Drug Eluting Stent, Onyx Frontier Drug Eluting Stent
- Where
- 61 sites in United States, Cyprus and 6 more
- Volunteers
- 3,100 people
- Sponsor
- Medstar Health Research Institute
Preterm Birth, Gestational Diabetes Mellitus (GDM)
Evaluation of Maternal and Neonatal Outcomes in Women Are Conceived Through Assisted Reproductive Technology Compared to Other Fertility Treatments and Naturally Conceived Women: It is a Retrospective Cohort Study Conducted Over a 5-year Period at a Fertility Center in a Lebanese Hospital
Background: The number of couples experiencing difficulties conceiving and seeking treatment for infertility has increased dramatically over time.
- Conditions
- Preterm Birth, Gestational Diabetes Mellitus (GDM), Gestational Hypertension
- Trial name
- non (NCT06836843)
- Testing
- Since this is an observational study rather than an interventional study, the exposure type refers to all potential factors influencing pregnancy both before and during pregnancy
- Where
- Lebanon
- Volunteers
- 1,000 people, healthy volunteers welcome
- Sponsor
- Lebanese University
ST-segment Elevation Myocardial Infarction (STEMI)
Impact of Stent Length and Diameter on Patients Undergoing Primary PCI
The goal of the study is to evaluate the Impact of coronary stent length and/or diameter in patients with ST segment myocardial infarction undergoing primary PCI, on Short term clinical outcomes.
- Trial name
- NCT04110691
- Volunteers
- 200 people
- Sponsor
- Assiut University
Abdominal Aortic Aneurysm
Outcomes of FEVAR and BEVAR to Treat Secondary Type 1 Endoleak After EVAR: A Prospective Multicentre Study
Ten percent of the population above 60 years develops an aortic abdominal aneurysm. In case of rupture, this pathology leads to death in more than 70% of the cases.
- Trial name
- NCT04532450
- Testing
- Branched / fenestrated aortic stent graft
- Volunteers
- 85 people
- Sponsor
- University Paul Sabatier of Toulouse
Peripheral Arterial Disease
RESveratrol To Improve Outcomes in oldeR pEople With PAD (the RESTORE Trial)
The RESTORE trial will determine whether resveratrol supplementation can improve walking performance in older people with lower extremity peripheral arterial disease (PAD).
- Trial name
- RESTORE (NCT02246660)
- Testing
- Resveratrol
- Where
- United States
- Volunteers
- 66 people
- Sponsor
- Northwestern University
Medication Non-adherence
Improving Adherence and Outcomes by Artificial Intelligence-Adapted Text Messages
Uncontrolled hypertension is a major cause of morbidity and mortality and many patients fail to take their antihypertensive medication as prescribed.
- Trial name
- AIM@BP (NCT02454660)
- Testing
- SMS (Text messages)
- Where
- 2 sites in United States
- Volunteers
- 49 people, healthy volunteers welcome
- Sponsor
- University of Michigan
Atrial Fibrillation
Feasibility Study to Improve AF Outcomes Using a Digital Application for CV Risk Reduction
The pilot portion of this study is to determine the feasibility of utilizing AF CARE to provide lifestyle modification support to patients with atrial fibrillation (AF).
- Trial name
- AFCARE (NCT04050982)
- Testing
- AF CARE, Usual Care
- Where
- United States
- Volunteers
- 11 people
- Sponsor
- Stanford University
Abdominal Aortic Aneurysm
Nellix Registry Study: EVAS-Global
Multicenter, single arm, open label, registry study with consecutive, eligible patient enrollment at each site. All subjects undergoing the Endovascular Aneurysm Sealing System (EVAS) with the Nellix®-System.
- Trial name
- EVAS FORWARD 2 (NCT02996396)
- Testing
- Nellix Endovascular Aneurysm Sealing System (Nellix®-System)
- Where
- 10 sites in Germany, Netherlands and 2 more
- Volunteers
- 48 people
- Sponsor
- Endologix
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.